Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results
Date:3/7/2012

tively impacted full year sales of Zailin and our edaravone products. We were encouraged, however, by the solid full year performance of our oncology drugs Endu, Sinofuan and Jiebaishu, as well as the strong sales growth of our new antibiotic drug Anxin."

Mr. Ren added, "Looking forward, we plan to allocate more sales resources to oncology drugs and new products. We are pleased that we began to sell Iremod, our new Category I Disease Modifying Anti-rheumatic Drug, in the first quarter of 2012. We believe that both Iremod and Qiangke, Shanghai Celgen's Recombinant Human TNF Receptor-IgG Fusion Protein for Injection, have exciting market potential in China."

Simcere holds a 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd.

Compound Edaravone Injection, a new drug being developed by Simcere, received clinical studies approval in February 2012 from the State Food and Drug Administration. Simcere expects to begin Phase I clinical trials of Compound Edaravone Injection in China during the first quarter of 2012. Simcere previously completed Phase I clinical trials of Compound Edaravone Injection in Australia.

2011 Fourth Quarter and Full Year Financial Results Total revenue for the fourth quarter of 2011 was RMB511.0 million (US$81.2 million), compared to RMB587.7 million for the same period in 2010. For the full year of 2011, total revenue was RMB2,040.5 million (US$324.2 million), which represented a decrease of 4.7% from RMB2,141.1 million in 2010.

Revenue from edaravone injection products under the brand names Bicun and Yidasheng totaled RMB172.3 million (US$27.4 million) for the fourth quarter of 2011, which was 33.7% of the Company's total revenue for the fourth quarter of 2011, and represented a decrease of 22.5% from RMB222.4 million for the same period in 2010. The decrease was primarily due to factors including the negative impact of changes to the tender process in cer
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound
2. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2011 Results
3. Simcere Pharmaceutical Group to Announce Third Quarter 2011 Financial Results on Monday, November 14, 2011
4. Simceres Iremod Receives SFDA New Drug Approval
5. Simceres Branded Generic Formulation Biqi Passes EU-GMP Inspection
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2011 Results
7. Simcere Pharmaceutical Group to Announce Second Quarter 2011 Financial Results on Tuesday, August 9, 2011
8. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
9. Simcere Pharmaceutical Group Filed 2010 Annual Report on Form 20-F
10. Simcere Announces Recent Progress of Qiangkes Registration
11. Simcere Pharmaceutical Group to Announce First Quarter 2011 Financial Results on Tuesday, May 10, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 As an industry-leading ...
(Date:6/2/2015)... , June 2, 2015  Ashion™ Advanced ... rapidly evolving genomic medicine industry, announced today ... service using Syapse Precision Medicine Platform. AIM ... (PMCs) with partner regional healthcare systems, providing ... genomic interpretation, education, and operational support. AIM ...
(Date:6/2/2015)... Mass., June 2, 2015 Today, Accuratus ... Capital Partners (Ampersand), announced the acquisition of the ... BioPharma Inc. (Array).  Accuratus was formed in July ... MN acquired Microtest Labs of Agawam, ... microbial testing services to the medical device and ...
Breaking Medicine Technology:Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 2Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 3Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3
... 2012 Stereotaxis, Inc. (NASDAQ:   STXS) today ... European market the V-Sono™ intracardiac echocardiography manipulator module ... Designed to manipulate accessory devices such as variable ... Vdrive™ platform combines magnetic navigation with the Odyssey™ ...
... (NASDAQ: KERX ), a biopharmaceutical company focused ... pharmaceutical products for the treatment of renal disease (the ... ended March 31, 2012. At March 31, ... and investment securities of $31.0 million, as compared to ...
Cached Medicine Technology:Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System 2Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System 3Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 4
(Date:6/2/2015)... 02, 2015 The Horizon Blue Cross ... that its Walking and Wellness Challenge, held this past ... has raised another $3,000 for the Boys & Girls ... challenge, recording 32,000 steps on her fitbit during her ... & Golf Club in Galloway Township. , When ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Did you wish ... what to get him, his family isn’t asking for presents, ... the team walking in Saturday’s Cure HHT DC Walk. , ... disease that causes malformed blood vessels leading to sudden and ... to appear when Ryder was 3 years old in the ...
(Date:6/2/2015)... Bradenton, MI (PRWEB) June 02, 2015 ... a new website to promote its handmade gourmet pizzas ... But even though the website is new, the recipes ... customers since 1995. The main feature of the site ... includes appetizing pictures and descriptions of all the items. ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 MAP Health ... and revenue cycle management for addiction treatment facilities, announced ... Vice President of Marketing. Mr. Smith will be responsible ... the awareness and visibility of MAP’s core message, products ... was the Marketing Manager at Cottonwood Financial in Irving, ...
(Date:6/2/2015)... 2015 ANT Wireless, proven innovator ... Pole Engineering’s (NPE) announcement of three next generation ... WASP-PoE-2 and WASP-PoE-3. WASP is a standalone ANT ... bridge solution that allows data collected from low-power ... Ethernet networks. , The new generation ...
Breaking Medicine News(10 mins):Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3
... FRANCISCO, Jan. 9 Blue Shield of California ... to manage the company,s rapid growth and pursue new strategic ... to spearhead the company,s success, Blue Shield chairman and CEO ... , Paul ...
... in 42 states have been sickened , , FRIDAY, Jan. 9 ... has sickened almost 400 Americans in 42 states remains unknown, ... expected. , The strain of salmonella has been identified as ... than 2,500 types of salmonella bacteria in the United States. ...
... class of the Henry Ford Health,System,s nursing recruitment program for ... In partnership with Oakland University , Henry Ford developed ... address the nursing shortage.,The U.S. Bureau of Labor Statistics estimates ... needed by 2012. , Oakland ...
... New Deal Means an Additional 480 positionsCAMP HILL, ... been selected by The Centers for Medicare and ... claims from hospitals and other institutional providers, physicians ... This contract also includes the processing of Home ...
... -- A unique discovery in a Florida State University ... with the potential to one day help scientists learn ... tissue where they are forming. , Jamila Horabin, associate ... has received a four-year, $1.2 million grant from the ...
... gene have disease relapse often within 5 years of apparent ... they have identified a rare subtype of a childhood leukemia ... the subtype of acute lymphoblastic leukemia (ALL) have a BCR-ABL1 ... children recently diagnosed with ALL, those with this gene tended ...
Cached Medicine News:Health News:Paul Markovich Named Chief Operating Officer of Blue Shield of California 2Health News:Paul Markovich Named Chief Operating Officer of Blue Shield of California 3Health News:Officials Still Seek Source of Salmonella Outbreak 2Health News:Highmark Medicare Services Awarded New Contract from Centers for Medicare & Medicaid Services 2Health News:Highmark Medicare Services Awarded New Contract from Centers for Medicare & Medicaid Services 3Health News:Researcher wins $1.2 million grant for gene regulation work 2Health News:Childhood Leukemia Subtype Resists Treatment 2
The Closer vascular closure device is a suture mediated closure system. It has a sheath-like profile and easy positioning. It has an innovative design which involves the needles outside the artery an...
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
These are coronary angiographic catheters used for selective coronary bypass angiography. The catheters curve configuration is ideally suited to select the internal mammary artery....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: